Hubungan antara Efek Samping Kemoterapi Pasien Kanker Payudara dengan Kualitas Hidup di Instalasi Rawat Jalan Rumah Sakit Ciremai
DOI:
https://doi.org/10.59024/jikas.v4i2.1717Keywords:
Breast Cancer Patients, Chemotherapy Cycle, Chemotherapy Side Effects, Quality of Life, WHOQOL-BREFAbstract
Breast cancer has a high global incidence and is the most prevalent cancer among women. Chemotherapy is a primary treatment option, but it may cause various physical and psychological side effects that can reduce patients’ quality of life. This study aimed to describe the characteristics of breast cancer patients undergoing chemotherapy and examine the relationship between chemotherapy side effects and quality of life at the outpatient unit of Ciremai Hospital. A cross-sectional analytical observational design was applied, with 30 patients receiving chemotherapy between May and July as the sample. Data were collected from medical records and the Indonesian version of the WHOQOL-BREF questionnaire, then analyzed using Spearman rank correlation. Most patients were aged 40–60 years, had a senior high school education, were housewives, and were in the 2nd or 5th chemotherapy cycle. Frequently reported side effects included nausea, vomiting, decreased appetite, early satiety, dizziness, sleep disturbances, body pain, and alopecia, mostly categorized as moderate. Most patients had a relatively poor quality of life. The analysis indicated a strong positive correlation between chemotherapy side effects and patients’ quality of life, with a Spearman correlation coefficient of 0.604 (p = 0.000 < 0.05), demonstrating a significant and strong relationship.
References
Afriano, R., Latifah, N., & Candradewi, S. F. (2025). Efek samping kombinasi doxorubicin dan cyclophosphamide pada pasien kanker payudara. Jurnal Farmasi Klinik Indonesia, 14(1), 42–50. https://doi.org/10.15416/ijcp.2025.v14i1.58230
Altun, I., & Sonkaya, A. (2018). The most common side effects experienced by patients were receiving first cycle of chemotherapy. Iranian Journal of Public Health, 47(8), 1218–1219. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6123577/
Anggraini, D., Semiarty, R., Rosyid, R., & Khambri, D. (2018). Faktor-faktor yang mempengaruhi kualitas hidup penderita kanker payudara di Kota Padang. Jurnal Endurance, 3(3), 562. https://doi.org/10.22216/jen.v3i3.3094
Bagiyo, W., & Siswantoro, E. (2023). Hubungan dukungan keluarga dengan kualitas hidup pada pasien kanker payudara yang menjalani kemoterapi. Enfermeria Ciencia, 1(1), 14–29. https://doi.org/10.56586/ec.v1i1.2
Borniger, C. B., Gaudier-Diaz, M. M., Zhang, N., Nelson, R. J., & DeVries, A. C. (2015). Cytotoxic chemotherapy increases sleep and sleep fragmentation in non-tumor-bearing mice. Brain, Behavior, and Immunity, 47, 218–227. https://doi.org/10.1016/j.bbi.2014.11.001
Cadamuro, S. A., Franco, J. O., Paiva, C. E., de Oliveira, M. A., & Paiva, B. S. R. (2020). Association between multiple symptoms and quality of life of paediatric patients with cancer in Brazil: A cross-sectional study. BMJ Open, 10(5), e035844. https://doi.org/10.1136/bmjopen-2019-035844
Eche, I. J., Khairunnisa, M., & Sari, N. P. (2020). Kualitas hidup anak dengan kanker yang menjalani kemoterapi. Jurnal Keperawatan Indonesia, 23(1), 45–52. https://doi.org/10.7454/jki.v23i1.963
Harefa, S. D. M. (2019). Gambaran kualitas hidup pasien kemoterapi di Rumah Sakit Santa Elisabeth Medan tahun 2019 [Skripsi, Sekolah Tinggi Ilmu Kesehatan Santa Elisabeth Medan].
Herawati, A., Rijal, S., Arsal, A. S. F., Purnamasari, R., Abdi, D. A., & Wahid, S. (2021). Karakteristik kanker payudara. Fakumi Medical Journal: Jurnal Mahasiswa Kedokteran, 1(1), 44–53. https://doi.org/10.33096/fmj.v1i1.8
Jannah, M., Kamal, A., & Amalia, R. (2022). Kualitas hidup pasien kanker payudara yang menjalani kemoterapi di Rumah Sakit Umum Banda Aceh. Jurnal Ilmiah Mahasiswa Fakultas Keperawatan, 6(2), 91–98.
Juwita, D. A., Almahdy, A., & Afdhila, R. (2018). Pengaruh karakteristik pasien terhadap kualitas hidup terkait kesehatan pada pasien kanker payudara di RSUP Dr. M. Djamil Padang, Indonesia. Jurnal Sains Farmasi & Klinis, 5(2), 126–133. https://doi.org/10.25077/jsfk.5.2.126-133.2018
Khairani, S., Keban, S. A., & Afrianty, M. (2019). Evaluation of drug side effects chemotherapy on quality of life (QOL) breast cancer patients at Hospital X in Jakarta. Jurnal Ilmu Kefarmasian Indonesia, 17(1), 9. https://doi.org/10.35814/jifi.v17i1.705
Ladesvita, F., & Sari, S. J. (2023). Activity daily living dan quality of life pasien kanker yang menjalani kemoterapi. Indonesian Journal of Health Development, 5(1), 30–38. https://doi.org/10.52021/ijhd.v5i1.115
Miaskowski, C., Paul, S. M., Harris, C. S., Shin, J., Oppegaard, K., Conley, Y. P., Hammer, M. J., Kober, K. M., & Levine, J. D. (2022). Determination of cutpoints for symptom burden in oncology patients receiving chemotherapy. Journal of Pain and Symptom Management, 63(1), 42–51. https://doi.org/10.1016/j.jpainsymman.2021.07.018
Parasian, J., Susilowati, Y., Nuryanti, N., Septimar, Z. M., & Haeriyah, S. (2024). Hubungan efek samping kemoterapi dengan kualitas hidup pasien kanker payudara di Rumah Sakit Kanker Dharmais Provinsi DKI Jakarta tahun 2023. Jurnal Ilmiah Ilmu Kesehatan dan Kedokteran, 2(1), 115–126. https://doi.org/10.55606/termometer.v2i1.2808
Rasjidi, I. (2019). Epidemiologi kanker pada wanita (Cet. 1). Sagung Seto.
Rosenberg, A. R., Dussel, V., Kang, T., Geyer, J. R., Gerhardt, C. A., Feudtner, C., & Wolfe, J. (2016). Psychological distress in parents of children with advanced cancer. JAMA Pediatrics, 170(9), 846–854. https://doi.org/10.1001/jamapediatrics.2016.0840
Sari, D. P., & Gumayesty, Y. (2016). Faktor-faktor yang berhubungan dengan kejadian kanker payudara di Poliklinik Onkologi RSUD Arifin Achmad Provinsi Riau. Al-Tamimi Kesmas: Jurnal Ilmu Kesehatan Masyarakat, 5(2), 84–92.
Sari, I. W., Rawitri, K., Dalimunthe, G. I., & Nasution, H. M. (2024). Gambaran efek samping obat kemoterapi pasien kanker payudara di RSUD Dr. Pirngadi Kota Medan. [Nama jurnal tidak tercantum], 4(1), 14–21.
Setiawan, M., Lestari, D. R., & Rachmawati, K. (2018). Hubungan lama kemoterapi dengan konsep diri pasien kanker payudara. Dinamika Kesehatan, 9(2), 429–443.
Sukma, A. A., Mawadani, M., Yuliyanasari, N., Prijambodo, T., & Primadina, N. (2020). The influence of health education (health literacy) on the compliance of PHBS behavior in elementary school students. Jurnal Implementa Husada, 1(2), 117–125. https://doi.org/10.30596/jih.v1i2.4900
von Minckwitz, G., Schneeweiss, A., Loibl, S., Salat, C., Denkert, C., Rezai, M., & Untch, M. (2014). Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (GeparSixto; GBG 66): A randomised phase 2 trial. The Lancet Oncology, 15(7), 747–756. https://doi.org/10.1016/S1470-2045(14)70160-3
Wahyuni, T. (2015). Hubungan antara frekuensi kemoterapi dengan kualitas hidup perempuan dengan kanker payudara yang menjalani kemoterapi di ruang kemoterapi RSUD AM Parikesit Tenggarong. Jurnal Ilmu Kesehatan, 3(2), 1–13.
Zhang, P., Yin, Y., Mo, H., Zhang, B., Wang, X., Li, Q., Yuan, P., Wang, J., Zheng, S., Cai, R., Ma, F., Fan, Y., & Xu, B. (2016). Better pathologic complete response and relapse-free survival after carboplatin plus paclitaxel compared with epirubicin plus paclitaxel as neoadjuvant chemotherapy for locally advanced triple-negative breast cancer: A randomized phase 2 trial. Oncotarget, 7, 60647–60656. https://doi.org/10.18632/oncotarget.10607
Downloads
Published
Issue
Section
License
Copyright (c) 2026 JURNAL ILMIAH KESEHATAN MASYARAKAT DAN SOSIAL
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
